Epidemiology of Parkinson disease in the city of Kolkata, India: A community-based study

Neurology

Volumn 75, Issue 15, 2010, Pages 1362-1369

  Das, S K ^a   Misra, A K ^a   Ray, B K ^a   Hazra, A ^b   Ghosal, M K ^c   Chaudhuri, A ^d   Roy, T ^a   Banerjee, T K ^e   Raut, D K ^f  

^a BANGUR INSTITUTE OF NEUROSCIENCES   (India)

^b INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^c Institute of Psychiatry   (India)

^d INDIAN STATISTICAL INSTITUTE   (India)

^e National Neurosciences Centre   (India)

^f ALL INDIA INSTITUTE OF HYGIENE AND PUBLIC HEALTH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUTOPSY; CASE CONTROL STUDY; ETHNICITY; FEMALE; FIELD WORK; FOLLOW UP; HEALTH SURVEY; HUMAN; HYPERTENSION; INCIDENCE; INDIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; RANDOM SAMPLE; RISK FACTOR; SCREENING TEST; STRUCTURED QUESTIONNAIRE; TOBACCO;

EID: 77958519745     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181f735a7     Document Type: Article

References (40)

1. Saha SP, Bhattacharya S, Das SK, Maity B, Roy T, Raut DK. Epidemiological study of neurological disorders in a rural population of Eastern India. J Indian Med Assoc 2003;101:299-300, 302-304. (Pubitemid 37237105)
2. Gourie-Devi M, Gururaj G, Satishchandra P, Sub-bakrishna DK. Prevalence of neurological disorders in Bangalore, India: a community-based study with a comparison between urban and rural areas. Neuroepidemiol-ogy 2004;23:261-268. (Pubitemid 39279475)
3. Das SK, Biswas A, Roy T, et al. A random sample survey for prevalence of major neurological disorders in Kolkata. Indian J Med Res 2006;124:163-172. (Pubitemid 44515797)
4. de Rijk MC, Breteler MM, Graveland GA, et al. Prevalence of Parkinson's disease in the elderly: the Rotterdam Study. Neurology 1995;45:2143-2146. (Pubitemid 27100237)
5. Morgante L, Rocca WA, Di Rosa AE, et al; for The Sicilian Neuro-Epidemiologic Study (SNES) Group. Prevalence of Parkinson's disease and other types of parkinsonism: a door-to-door survey in three Sicilian municipalities. Neurology 1992;42:1901-1907.
6. Milanov I, Kmetski TS, Lyons KE, Koller WC. Prevalence of Parkinson's disease in Bulgarian Gypsies. Neuroepide-miology 2000;19:206-209. (Pubitemid 30428848)
7. Melcon MO, Anderson DW, Vergara RH, Rocca WA. Prevalence of Parkinson's disease in Junín, Buenos Aires Province, Argentina. Mov Disord 1997;12:197-205.
8. Wang SJ, Fuh JL, Teng EL, et al. A door-to-door survey of Parkinson's disease in a Chinese population in Kinmen [published erratum appears in Arch Neurol 1996;53:508]. Arch Neurol 1996;53:66-71.
9. Chen RC, Chang SF, Su CL, et al. Prevalence, incidence, and mortality of PD: a door-to-door survey in Ilan County, Taiwan. Neurology 2001;57:1679-1686.
10. Kusumi M, Nakashima K, Harada H, Nakayama H, Taka-hashi K. Epidemiology of Parkinson's disease in Yonago City, Japan: comparison with a study carried out 12 years ago. Neuroepidemiology 1996;15:201-207. (Pubitemid 26194303)
11. Osuntokun BO, Adeuja AO, Schoenberg BS, et al. Neurological disorders in Nigerian Africans: a community-based study. Acta Neurol Scand 1987;75:13-21. (Pubitemid 17027275)
12. Zhang ZX, Román GC. Worldwide occurrence of Parkinson's disease: an updated review. Neuroepidemiology 1993;12:195-208.
13. Bharucha NE, Bharucha EP, Bharucha AE, Bhise AV, Schoenberg BS. Prevalence of Parkinson's disease in the Parsi community of Bombay, India. Arch Neurol 1988;45: 1321-1323.
14. Rajput AH, Offord KP, Beard CM, Kurland IT. Epidemiology of parkinsonism: incidence, classification and mortality. Ann Neurol 1984;16:278-282.
15. MacDonald BK, Cockerell OC, Sander JW, Shorvon SD. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000;123:665-676. (Pubitemid 30162716)
16. Granieri E, Carreras M, Casetta I, et al. Parkinson's disease in Ferrara, Italy, 1967 through 1987. Ach Neurol 1991; 48:854-857.
17. Rosati G, Granieri E, Pinna L, et al. The risk of Parkinson's disease in Mediterranean people. Neurology 1980; 30:250-255. (Pubitemid 10133759)
18. Jenkins AC. Epidemiology of parkinsonism in Victoria. Med J Aust 1966;2:496-502.
19. Ashok PP, Radhakrishnan K, Sridharan R, Mousa ME. Epidemiology of Parkinson's disease in Benghazi, NorthEast Libya. Clin Neurol Neurosurg 1986;88:109-113. (Pubitemid 16047274)
20. Wang YS, Shi YM, Wu ZY, He YX, Zhang BZ; for Coor-dinational Group of Neuroepidemiology PLA. Parkinson's disease in China. Chin Med J (Engl) 1991;104:960-964.
21. Bennett DA, Beckett LA, Murray AM, et al. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med 1996;334:71-76.
22. Soleman N, Chandramohan D, Shibuya K. Verbal autopsy: current practices and challenges. Bull World Health Organ 2006;84:239-245. (Pubitemid 43352406)
23. Ahmad O, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M. Age Standardization of Rates: A New WHO Standard. Geneva: World Health Organization; 2000. GPE Discussion Paper Series No. 31.
24. de Rijk MC, Rocca WA, Anderson DW, Melcon MO, Breteler MM, Maraganore DM. A population perspective on diagnostic criteria for Parkinson's disease. Neurology 1997;48:1277-1281. (Pubitemid 27240548)
25. Mutch WJ, Smith WC, Scott RF. A screening and alerting questionnaire for parkinsonism. Neuroepidemiology 1991;10:150-156.
26. Ragothaman M, Murgod UA, Gururaj G, Kumaraswamy SD, Muthane U. Lower risk of Parkinson's disease in an admixed population of European and Indian origins. Mov Disord 2003;18:912-914. (Pubitemid 37021166)
27. Goldberg ID, Kurland LT Mortality in 33 countries from diseases of the nervous system. World Neurol 162;3:444-465.
28. Kimura H, Kurimura M, Wada M, et al. Female preponderance of Parkinson's disease in Japan. Neuroepidemiol-ogy 2002;21:292-296. (Pubitemid 36151500)
29. Miller DB, Ali SF, O'Callaghan JP, Laws SC. The impact of gender and estrogen on striatal dopaminergic neurotox-icity. Ann NY Acad Sci 1998;844:153-165.
30. Behari M, Srivastava AK, Das RR, Pandey RM. Risk factors of Parkinson's disease in Indian patients. J Neurol Sci 2001;190:49-55. (Pubitemid 33713021)
31. Baldereschi M, Di Carlo A, Rocca WA, et al; for ILSA Working Group. Italian Longitudinal Study on Aging Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. Neurology 2000;55: 1358-1363.
32. Van Den Eeden SK, Tanner CM, Bernstein AL, et al. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 2003;157:1015-1022.
33. O'Reilly EJ, McCullough ML, Chao A, et al. Smokeless tobacco use and the risk of Parkinson's disease mortality. Mov Disord 2005;20:1383-1384. (Pubitemid 41645921)
34. Turnbull C. Vascular parkinsonism: an important update. Age Ageing 2005;34:97-98.
35. Skoog I, Gustafson D. Update on hypertension and Alzheimer's disease. Neurol Res 2006;28:605-611. (Pubitemid 44444422)
36. Zijlmans JC, Katzenschlager R, Daniel SE, Lees AJ. The L-dopa response in vascular parkinsonism. J Neurol Neu-rosurg Psychiatry 2004;75:545-547. (Pubitemid 38406649)
37. Das SK, Banerjee TK, Biswas A, et al. A prospective community-based study of stroke in Kolkata, India. Stroke 2007;38:906-910. (Pubitemid 46568451)
38. Biswas A, Gupta A, Naiya T, et al. Molecular pathogenesis of Parkinson's disease: identification of mutations in the Parkin gene in Indian patients. Parkinsonism Relat Disord 2006;12:420-426. (Pubitemid 44416293)
39. Sun AY, Wang Q, Simonyi A, Sun GY. Botanical phenolics and brain health. Neuromolecular Med 2008;10:259-274.
40. Pandey N, Strider J, Nolan WC, Yan SX, Galvin JE. Cur-cumin inhibits aggregation of alpha-synuclein. Acta Neu-ropathol 2008;115:479-489.